Concise Analysis of the North American Home Healthcare Market - Forecasts To 2017

News provided by

Jan 31, 2014, 05:00 ET

DUBLIN, January 31, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/b3hk4x/north_american) has announced the addition of the "Concise Analysis of the North American Home Healthcare Market - Forecasts To 2017" report to their offering.

Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The North American home healthcare market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. The home healthcare market includes products, services, and telehealth. The home care product category comprises home care testing, screening and monitoring devices, home healthcare therapeutic equipment, mobility assist and other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.

The most significant healthcare trend witnessed recently is the shift of treatment from hospitals to home in order to gain a cost advantage and reduce hospital expenditure. The move from treatment to proactive monitoring is also opening up new opportunities for the home healthcare market. Patients prefer home healthcare over hospitals for the convenience, privacy, and cost-effectiveness it offers. Factors like innovation, easy availability, aging demographics, and increasing chronic diseases drive the U.S. market, which has the largest share in terms of revenue. Canada is also a significant country of North American region. The rising healthcare cost and increasing incidences of chronic ailments are forcing Canadian government to move towards home healthcare. This factor has made home healthcare a lucrative market for many companies to invest. However, cut in Medicare payments to home health agencies and risk to the safety of home healthcare workers are factors limiting the growth of this market.

The US dominated the North American home healthcare market in 2012 and is expected to maintain its position in the coming five years, owing to the rising aging population, increasing chronic diseases, technological developments for various home use applications, positive response to home-based devices, increasing awareness, and proper insurance coverage in the country. Canada is expected to grow steadily, due to increasing awareness regarding home based devices, and increasing prevalence of lifestyle diseases such as diabetes, obesity, and cardiovascular diseases and various initiatives taken by government to promote home healthcare.

The prominent home healthcare service provider companies are Apria Healthcare Group (U.S.), Gentiva Health Service Inc. (U.S.) and Amdisys, Inc. (U.S.) while key home healthcare product manufacturing companies are Alere, Inc. (U.S.), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Se & Co KGAa (Germany), GE Healthcare (U.K), Philips Healthcare (The Netherlands), and Roche Holdings (Switzerland).

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Home Healthcare Testing, Screening & Monitoring Market

5 Home Healthcare Therapeutic Equipment

6 Mobility Assist & Other Devices

7 Nutrition